Skip to content
Wholesale? Apply for an account.

Meet the Visionaries

Founded by Amanda Davis and Meghan Stogner, we believe in simple, natural solutions that support overall well-being.

Founder

Amanda Davis

After suffering a Stroke and Pulmonary Embolism in her late 30’s, Amanda decided to take her recovery to a new level. During her rehabilitation, it was clear that inflammation, pain and daily discomfort was her new normal. While searching for more natural ways to complement her recovery, her research led to plant-based wellness as part of her daily routine.

Every ingredient was chosen with real people in mind-people who are looking for balance, simplicity and trust.

Co-Founder

Meghan Stogner

Meghan has spent her career listening to people. As a Trauma Therapist, she has had the privilege of helping people during their most vulnerable moments in life. Alongside her co-founder, they set out to create a product that reflects the same values she brings to her work: intention, transparency, and whole-body care.

While therapy addresses the body’s internal landscape, this CBD cream is an extension to any holistic practice. We understand the importance of overall wellness.

Green Draggon Naturals

Benefits | How it works | Efficacy of GDN CBD Cream
Same plant, different results

THC vs. CBD

Feature THC GDN

Psychoactive

Produces a euphoric high and intoxicating effects.

Promotes Calm

Supports balance, relaxation, and mental clarity.

Supports Homeostasis

Helps maintain the body's natural equilibrium.

CB1 Interaction

Interacts with CB1 receptors without directly activating them.

Reward System Activation

Triggers dopamine release and euphoric effects.

Intoxication

Causes mind-altering and intoxicating effects.

Cannabinoid Guide

Understand how major cannabinoids affect the body.

Binds strongly to CB1 receptors, especially in the brain, leading to psychoactive effects like euphoria and altered perception.

Similar to Delta 9 but with slightly less affinity for CB1 receptors, resulting in milder psychoactivity.

Does not bind directly but influences ECS activity by modulating receptor behavior and increasing levels of endocannabinoids like anandamide.

Weakly binds to CB1 receptors, producing mild sedative effects.

Primarily interacts with CB2 receptors and other non-ECS targets, offering therapeutic benefits without intoxication.

In its raw form, it does not bind to CB1 or CB2 receptors until decarboxylated (heated), at which point it converts to THC.

Key Potential Benefits

Medicinal and Physical Attributes of CBD